B.I. Sky Global Ltd.
Tracked across 4 events · 29 articles · First seen Jul 29, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: As the subsidiary operating the Valitic brand, B.I. Sky Global directly benefits from the increased consumer trust and sales potential.
Aug 05, 2026 · 7 articles
Business
Impact: Subsidiary operating Valitic; directly responsible for the milestone.
Jul 29, 2026 · 7 articles
Business
Impact: B.I. Sky Global maintained a high gross margin of 90.9% and its VALITIC brand remains a top seller on Amazon. The subsidiary is expanding sales channels to diversify revenue.
Aug 31, 2026 · 8 articles
Business
Innocan Pharma Corporation announced on September 9, 2026 its intention to complete a private placement of up to 535,000 units at C$1.87 per unit, for gross proceeds of up to C$1,000,000. Each unit consists of…
Impact: B.I. Sky Global Ltd. is a 60%-owned subsidiary of Innocan Pharma focused on online sales of wellness products. The offering's proceeds may indirectly support its operations, but it is not directly involved in the placement.
Sep 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Track B.I. Sky Global Ltd. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard